Results 171 to 180 of about 25,400 (245)

Clostridioides difficile infections in seven Brazilian hospitals during the COVID-19 pandemic: hand hygiene and antimicrobial consumption. [PDF]

Rev Inst Med Trop Sao Paulo
Gonçalves LA, Santos ILD, Porto APM, Viana Junior AB, Carijo JH, Carillho CDM, Cocentino BCB, Passos LN, Varkulja GF, Guimarães T, Costa SF.   +10 more
europepmc   +1 more source

<i>Clostridioides difficile</i> Colonization and Infection in Pediatric Oncology and Stem Cell Transplant Patients. [PDF]

Open Forum Infect Dis
Willis DN, Dubberke ER, Hayashi RJ, Tarr PI, Haslam DB, Hink T, Luo J, Tao Y, Padhye A, Hall EM, Storch GA.   +10 more
europepmc   +1 more source

Clostridioides difficile infection in nucleic acid amplification test-positive/toxin-negative patients: to treat or not to treat. [PDF]

Korean J Intern Med
Gweon TG.
europepmc   +1 more source

Bacterial Gastrointestinal Infections in Pediatric Inflammatory Bowel Disease (PIBD)-A Single-Center Experience of Epidemiology, Management, and Outcome. [PDF]

Diagnostics (Basel)
Planka RM, Hauer AC, Bauchinger S, Kohlmaier B.   +3 more
europepmc   +1 more source

Clostridioides difficile: situaci?n actual

[ES]Introducci?n: Clostridioides difficile es el agente causante del cuadro diarreico m?s frecuente en el ?mbito hospitalario. Est? relacionado con la alteraci?n de la microbiota intestinal, debida al consumo de antibi?ticos y de inhibidores de la bomba de protones, a edades avanzadas y a la enfermedad inflamatoria intestinal, entre otros.
openaire   +1 more source

Smoking and <i>Clostridioides difficile</i> Colonization in Adults Aged ≥40 Years: Findings from a Community-Based Gut Microbiota Study. [PDF]

Infect Drug Resist
Chen HM, Yang TW, Ko WC, Hung YP, Tsai CS, Tsai PJ.   +5 more
europepmc   +1 more source

Clostridioides difficile Infection Among Hospitalized Patients With Cancer.

JAMA Netw Open
Roldan GA, Goble S, Davie T, Fletcher J, Campoverde L, Mendoza MA, Moutsoglou DM.   +6 more
europepmc   +1 more source

Clinical and Pharmacoeconomic evaluation of Fidaxomicin in patients over 65 years of age and immunocompromised patients with recurrent and refractory Clostridioides difficile infection. [PDF]

BMC Infect Dis
Alram I, Wingen-Heimann SM, Engelhard M, Pfeiffer N, Vehreschild JJ, Vehreschild MJGT, Pütz SM.   +6 more
europepmc   +1 more source

Significant Increase in <i>Clostridioides difficile</i> Mortality During the COVID-19 Pandemic: A Nationwide Study. [PDF]

Gastro Hep Adv
Besney J, Ray CM, Buhler KA, Krawchuk S, Jijon H, Lu C, Seow CH, Novak KL, St-Pierre J, Singh S, Panaccione R, Kaplan GG, Ma C.   +12 more
europepmc   +1 more source